课题基金 / 基金详情

MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS

MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESIS
肿瘤促癌机制
批准号:
6350138
负责人:
RICHARD E HONKANEN
金额:
$23.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2004-01-31

项目摘要

项目成果

RICHARD E HONKANEN的其他基金

相似基金

相关文献

中文摘要
翻译
确定肿瘤细胞发生的机制
英文摘要
Determining the mechanisms that allow neoplastic cells to undergo uncontrolled proliferation is crucial to understanding carcinogenesis. Several recent studies indicate that protein phosphatases, like protein kinases, play important and specific roles in cell-cycle regulation; thus alterations in the expression or regulation of these proteins may affect cell-cycle progression and could even allow cells to undergo unregulated proliferation. A role for protein phosphatases in the tumor promotion process has also emerged from studies with okadaic acid, microcystin-LR, and calyculin A, three highly specific and potent inhibitors of certain serine/threonine protein phosphatases (PPases) that have tumor promoting activity. We have cloned and characterized three human PPases, and one, designated PP5, is particularly attractive for further studies. PP5 is potently inhibited by okadaic acid and calyculin A, two potent tumor promoters in mouse skin. However, unlike the other known PPases, which are expressed at constant levels, PP5 expression is high during log phase growth and low or undetectable in quiescent or differentiated cell cultures. The expression of PP5 is induced by the addition of serum and/or 17beta-estradiol in some cell types, and the inhibition of PP5 expression enhances the ability of both the p53 tumor suppressor protein and dexamethasone, a synthetic glucocorticoid agonist, to induce the expression of the p21 cyclin- dependent kinase inhibitor protein in A549 cells. Together these studies suggest that PP5 plays an important role in the regulation G1/S- phase transition. This proposal is designed to test the hypothesis that protein phosphatases play an important role in cell cycle progression; thus, the interference of their activity may contribute to the aberrant proliferative behavior of neoplastic cells. These studies will focus on the following specific aims: Aim 1. Further characterize the roles of PP5 in the normal and aberrant control of cell cycle progression. Aim 2.Characterize the relationship of PP5 in glucocorticoid mediated inhibition of cell growth and "cross talk" between signaling networks induced by hormones and growth factors. Aim 3.Characterize the mechanisms regulating the expression of PP5. Through these studies we hope to further characterize the role of protein phosphatases in the regulation of cell cycle and gain insight into the how protein phosphatases may be involved in the aberrant proliferation of neoplastic cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methods to enable cholesterol catabolism in human monocyte derived macrophages
  • 批准号:
    8337404
  • 项目类别:
  • 资助金额:
    $33.41万
  • 财政年份:
    2011
  • 负责人:
    RICHARD E HONKANEN
  • 依托单位:
Methods to enable cholesterol catabolism in human monocyte derived macrophages
  • 批准号:
    8668135
  • 项目类别:
  • 资助金额:
    $33.41万
  • 财政年份:
    2011
  • 负责人:
    RICHARD E HONKANEN
  • 依托单位:
Methods to enable cholesterol catabolism in human monocyte derived macrophages
  • 批准号:
    8181189
  • 项目类别:
  • 资助金额:
    $35.91万
  • 财政年份:
    2011
  • 负责人:
    RICHARD E HONKANEN
  • 依托单位:
Methods to enable cholesterol catabolism in human monocyte derived macrophages
  • 批准号:
    8496113
  • 项目类别:
  • 资助金额:
    $32.41万
  • 财政年份:
    2011
  • 负责人:
    RICHARD E HONKANEN
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: